Pfizer beats earnings estimates, targets $2.5 billion in additional cost cuts
- The company is also counting on newer medicines to lessen its dependence on aging blockbuster drugs
- Pfizer has said it expects to return to stronger growth after 2028
covid
VideoChina marks muted 5th anniversary of first Covid death
Covid still kills 1,700 a week: WHO
AstraZeneca to withdraw COVID vaccine globally as demand dips
Eiffel Tower topped pre-Covid visitor numbers in 2023
Pakistan to test two percent of arriving passengers for new COVID-19 variant as prevention strategy
China reports no ‘unusual or novel pathogens’ in respiratory illnesses upsurge
UK regulator approves updated Pfizer-BioNTech COVID vaccine
SpecialPakistan Medical Association warns fifth COVID-19 wave to hit country by end of January
